ISIN | CH0203270225 |
---|---|
Valor Number | 20327022 |
Bloomberg Global ID | UBSHQDC SW |
Fund Name | UBS (CH) Equity Fund - Swiss High Dividend (CHF) Q-dist |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland | |
Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | This actively managed equity fund invests in Swiss companies.|The fund focuses on companies with strong fundamentals that are expected to be able to pay sustainable dividends.|The fund offers a diversified portfolio across capitalization levels and sectors with a maximum single stock concentration of 10% - providing better diversification than standard Swiss equity indices.|UBS High Dividend Funds have typical equity risk characteristics and are suitable for risk tolerant investors who are willing to bear the risk and volatility of equity investments. |
Peculiarities |
Current Price * | 159.54 CHF | 15.04.2025 |
---|---|---|
Previous Price * | 157.06 CHF | 14.04.2025 |
52 Week High * | 174.01 CHF | 20.03.2025 |
52 Week Low * | 146.77 CHF | 16.04.2024 |
NAV * | 159.54 CHF | 15.04.2025 |
Issue Price * | 159.43 CHF | 15.04.2025 |
Redemption Price * | 159.43 CHF | 15.04.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 730,481,794 | |
Unit/Share Assets *** | 19,506,826 | |
Trading Information SIX |
YTD Performance | +1.69% |
27.12.2024 - 15.04.2025
27.12.2024 15.04.2025 |
---|---|---|
1 month | -8.15% |
17.03.2025 - 15.04.2025
17.03.2025 15.04.2025 |
3 months | -0.12% |
15.01.2025 - 15.04.2025
15.01.2025 15.04.2025 |
6 months | -2.21% |
15.10.2024 - 15.04.2025
15.10.2024 15.04.2025 |
1 year | +7.09% |
15.04.2024 - 15.04.2025
15.04.2024 15.04.2025 |
2 years | +13.31% |
17.04.2023 - 15.04.2025
17.04.2023 15.04.2025 |
3 years | +11.55% |
19.04.2022 - 15.04.2025
19.04.2022 15.04.2025 |
5 years | +45.09% |
15.04.2020 - 15.04.2025
15.04.2020 15.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 9.78% | |
---|---|---|
Nestle SA | 9.67% | |
Novartis AG Registered Shares | 9.62% | |
Zurich Insurance Group AG | 8.65% | |
UBS Group AG | 8.34% | |
ABB Ltd | 6.23% | |
Swiss Re AG | 6.23% | |
Givaudan SA | 4.57% | |
Holcim Ltd | 4.34% | |
Lonza Group Ltd | 3.51% | |
Last data update | 28.02.2025 |
TER | 0.85% |
---|---|
TER date | 31.10.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.84% |
Ongoing Charges *** | 0.84% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |